Singaporean health tech startup MiyaHealth gets additional funding for Southeast Asia, Europe expansion

Singapore-based health know-how firm MiyaHealth has obtained an undisclosed sum of funding from HealthXCapital, Central Capital Ventura, and SEEDS Capital. 

This comes on prime of the $4.8 million it raised in a pre-Series A spherical earlier this 12 months.

Founded in 2019, the startup affords two know-how platforms: MiyaPatient, a navigation platform that helps sufferers handle their power sickness, and MiyaPayor, which mixes AI-powered claims processing and predictive analytics. It is developing with a 3rd providing, MiyaProvider, which is meant to boost sufferers’ expertise in hospitals and clinics.

At current, over 3,000 medical suppliers and 12,000 physicians have been utilizing these platforms.

WHAT IT’S FOR

The firm stated the additional funding will assist enhance its product improvement, hiring, and expansion plans. Specifically, it can help in its efforts to deploy MiyaPatient for the primary time in Europe and the MiyaPayor and MiyaProvider platforms in Indonesia and the Philippines. 

THE LARGER TREND

Alongside this announcement, MiyaHealth additionally disclosed that it’s making ready to launch a Series A fundraiser “within the subsequent six months,” the proceeds of which can assist “additional develop its product suite, increase its operations globally, and proceed embarking on collaborations with key stakeholders transferring ahead”.

Asia’s consumer-centric digital health ecosystem continues to develop with rising demand. It has been projected that the area’s digital health market might attain $100 billion in worth by 2025 from $37 billion in 2020, primarily based on a report by McKinsey & Co.